| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 54.201 | - | - |
| Total Income - EUR | 146 | 74 | 2.014 | 1.759 | 1.909 | 573 | 736 | 56.801 | - | - |
| Total Expenses - EUR | 3.345 | 12.864 | 46.754 | 85.307 | 61.441 | 72.029 | 62.899 | 42.245 | - | - |
| Gross Profit/Loss - EUR | -3.199 | -12.790 | -44.741 | -83.547 | -59.532 | -71.456 | -62.163 | 14.556 | - | - |
| Net Profit/Loss - EUR | -3.199 | -12.792 | -44.741 | -83.547 | -59.532 | -71.456 | -62.163 | 14.556 | - | - |
| Employees | 0 | 0 | 0 | 3 | 2 | 2 | 2 | 2 | - | - |
Check the financial reports for the company - Pro Pharma Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.527 | 27.325 | 56.630 | 46.132 | 36.203 | 27.585 | 23.101 | 20.757 | - | - |
| Current Assets | 110 | 30.903 | 68.916 | 22.484 | 46.830 | 52.418 | 54.622 | 108.689 | - | - |
| Inventories | 11 | 9.385 | 2.353 | 3.591 | 23.234 | 22.794 | 23.312 | 23.384 | - | - |
| Receivables | 0 | 0 | 0 | 0 | 3.571 | 8.068 | 11.709 | 65.984 | - | - |
| Cash | 99 | 21.518 | 66.562 | 18.894 | 20.024 | 21.556 | 19.601 | 19.321 | - | - |
| Shareholders Funds | -3.867 | -16.495 | -60.956 | -143.385 | -200.140 | -267.802 | -324.026 | -310.475 | - | - |
| Social Capital | 99 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | - | - |
| Debts | 5.504 | 74.723 | 186.502 | 212.002 | 283.173 | 347.912 | 401.763 | 439.934 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Pro Pharma Medica Srl